Everolimus in Treating Patients With Recurrent Low-Grade Glioma

Summary

This phase II trial studies how well everolimus works in treating patients with recurrent low-grade glioma. Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth or by blocking blood flow to the tumor.

Timeline

Start

2009-01-23

Primary completion

2017-06-12

Completion

2017-11-13

Drugs

Indications